Changing GPs' prescription patterns through guidelines and feedback. Intervention study

Pharmacoepidemiology and Drug Safety

Volumn 16, Issue 6, 2007, Pages 695-704

  Schaefer, Kirsten ^a   Hansen, Anders Onsberg ^a,b   Maerkedahl, Henrik ^c   Rehfeld, Claus ^d   Birk, Hans Okkels ^a,e   Henriksen, Lars Onsberg ^a  

^a Department of Quality and Development   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c Rehfeld Partners A/S ^*  (Denmark)

^d Rehfeld Partners A/S   (Denmark)

^e UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Behaviour change; Clinical guidelines; Denmark; Feedback; General practice; General practitioners; Health economics; Outreach visits; Prescribing

Indexed keywords

GENERIC DRUG;

ARTICLE; BEHAVIOR CHANGE; CONTROLLED STUDY; COST CONTROL; DENMARK; FEEDBACK SYSTEM; GENERAL PRACTICE; GENERAL PRACTITIONER; HEALTH CARE ACCESS; HEALTH CARE COST; HUMAN; PRACTICE GUIDELINE; PRESCRIPTION; PRIMARY HEALTH CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; REGISTER;

DRUG COSTS; DRUG UTILIZATION; FEEDBACK; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES;

EID: 34447270795     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1404     Document Type: Article

References (13)

1. Schneeweiss S, Schöffski O, Selke GW. What is Germany's experience on reference based drug pricing and the etiology of adverse health outcomes or substitution? Health Policy 1998; 44: 253-260. DOI: 10.1016/S0168-8510(98)00023-2.
2. Tilson L, Bennett K, Barry M. The potential impact of implementing a system of generic substitution on the community drug schemes in Ireland. Eur J Health Econ 2005; 50: 267-273 DOI: 10.1007/ s10198-005-0302-5.
3. Damsgaard JJ, Schaefer K, Folke PE, et al. Beozodiazepinforbruget i Hvalsoe. Kan forbruget reduceres yderligere i et omraade, hvor det tidligere er nedsat med 38%? [in Danish: Benzodiazepine consumption in Hvalsoe. An attempt to reduce the consumption of benzodiazepine in an area in which earlier intervention reduced consumption by 38%]. Ugeskr Laeger 1998; 160: 1950-1953.
4. Gencarelli DM. Medicaid prescription drug coverage: state efforts to control costs. NHPF Issue Brief 2003; 790: 1-17.
5. Tilson L, McGowan B, Ryan M, Barry M. Generic drug utilisation on the General Medical Services (GMS) scheme in 2001. Ir Med J 2003; 96: 176-179.
6. McGowan B, Bennett K, Tilson L, Barry M. Cost effective prescribing of proton pump inhibitors (PPIs) in the GMS Scheme. Ir Med J 2005; 98: 78-80.
7. van Hout BA, Klok RM, Brouwers JR, Postma MJ. A pharmacoeconomic comparison of the efficacy and costs of pantoprazole and omeprazole for the treatment of peptic ulcer or gastrooesophageal reflux disease in the Netherlands. Clin Ther 2003; 25: 635-646. DOI: 10.1016/ S0149-2918(03)80101-7.
8. Grimshaw JM, Thomas RE, MacLennan G, et al. Effectiveness and efficiency of guideline dissemination and implementation strategies. Final report. Aberdeen: Health Services Research Unit, University of Aberdeen, 2002.
9. Grimshaw JM, Russell IT. Do clinical guidelines change medical practice? A systematic review of rigorous evaluations. Lancet 1993; 342: 1317-1322. DOI: 10.1016/0140-6736(93)92244-N.
10. Zwar N, Henderson J, Britt H, et al. Influencing antibiotic prescribing by prescriber feedback and management guidelines: a 5-year follow-up. Fam Pract 2002; 19: 12-17. DOI:10.1093/fampra/ 19.1.12.
11. Jamtvedt G, Young JM, Kristoffersen DT, et al. Audit and feedback: effects on professional practice and health care outcomes. The Cochrane Database of Systematic Reviews 2003. Issue 3. CD000259. DOI: 10.1002/14651858.CD000259.
12. Bero LA, Grilli R, Grimshaw JM, et al. Closing the gap between research and practice: an overview of systematic reviews of interventions to promote the implementation of research findings. Br Med J 1998; 317: 465-468.
13. Henriksen LO, Schaefer K, Damsgaard J. Who prescribed drugs in general practice in a Danish county? PD Safe 2005; 14(Supplement 1): S12. DO1: 10.1002/pds. 1127.